| Nom du produit | Saxagliptin |
|---|---|
| Numéro CAS | 361442-04-8 |
| Formule moléculaire | C18H25N3O2 |
| Poids moléculaire | 315.41 g/mol |
| Apparence | Poudre cristalline blanche à blanc cassé |
| Essai (HPLC) | ≥98% |
| Perte au séchage | ≤0.5% |
| Résidu au feu | ≤0.2% |
| Métaux lourds | ≤ 10 ppm |
| Point de fusion | ~100-105°C |
| Rotation spécifique | [α]D20 = -10° to -12° (c=1, methanol) |
Besoin d'aide ? Contacter notre équipe

Onglyza, BMS-477118, Saxagliptin hydrochloride, (1S,3S,5S)-2-[(2S)-2-Amino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile, saxagliptin base
Saxagliptin is a selective DPP-4 inhibitor that has quietly become a go-to for type 2 diabetes management. Its real edge? It inhibits the enzyme that degrades incretin hormones, so patients get better glucose control without the weight gain or hypoglycemia risk that often comes with other therapies. That’s why it’s a mainstay in combination therapies and a solid choice for formulators looking to build out their diabetes portfolio.
We supply saxagliptin as a high-purity API, manufactured under strict quality controls. Every batch is tested via HPLC to ensure ≥98% purity, and we back it with a full COA and MSDS. Whether you need 1 kg for R&D or a metric ton for commercial production, we handle it with consistent quality and on-time delivery to any port worldwide.